Literature DB >> 13070475

[The treatment of pemphigus vulgaris with heparin].

M MATTHES.   

Abstract

Entities:  

Keywords:  HEPARIN/therapeutic use; PEMPHIGUS

Mesh:

Substances:

Year:  1953        PMID: 13070475     DOI: 10.1007/bf01472083

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


× No keyword cloud information.
  8 in total

1.  Failure of in vitro inhibition of hyaluronidase by salicylates.

Authors:  G I Swyer
Journal:  Biochem J       Date:  1948       Impact factor: 3.857

2.  Hyaluronidase in fluid administration; a preliminary report.

Authors:  J SCHWARTZMAN; A T HENDERSON; W E KING
Journal:  J Pediatr       Date:  1948-09       Impact factor: 4.406

3.  Heparin tolerance in rheumatic fever.

Authors:  D G ABRAHAMS; L E GLYNN
Journal:  Clin Sci       Date:  1949-09       Impact factor: 6.124

4.  Successful treatment of pemphigus with heparin.

Authors:  J P MAGNER; R C MANSON; A PEPPLE
Journal:  AMA Arch Derm Syphilol       Date:  1951-09

5.  Collagen disease.

Authors:  P KLEMPERER
Journal:  Am J Med       Date:  1951-04       Impact factor: 4.965

6.  The mucopolysaccharides of the ground substance of connective tissue.

Authors:  K MEYER; M M RAPPORT
Journal:  Science       Date:  1951-05-25       Impact factor: 47.728

7.  Production of bullae in pemphigus with hyaluronidase.

Authors:  M L GRAIS
Journal:  J Invest Dermatol       Date:  1949-11       Impact factor: 8.551

8.  [Expanding the knowledge on mucopolysaccharides, specifically on heparins].

Authors:  R MARBET; A WINTERSTEIN
Journal:  Experientia       Date:  1952-01-15
  8 in total
  2 in total

1.  [Histochemical findings in "pemphigus with subepidermal vesicle formation" with a contribution to the pathogenesis of supepidermal vesicle formation].

Authors:  O BRAUN-FALCO
Journal:  Arch Klin Exp Dermatol       Date:  1960

2.  [Effect of hyaluronidase and heparin on experimental skin vesicle].

Authors:  O BRAUN-FALCO; R GEIMER
Journal:  Arch Dermatol Syph       Date:  1953
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.